Angelo DePalma
Angelo DePalma
Latest posts from :
Personalized medicine: A...
*Angelo DePalma reports on how personalized medicine may further weaken the ...
Designing adherence programs:...
Kenneth Youngstein, CEO of Biocom, on the regulatory, strategic, and tactical ...
Forecasting for orphan drugs: The...
Gianclaudio Floria, senior manager for business planning and analysis at ...